MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis

NYSE:MYTE • US55406W1036

7.64 USD
-0.2 (-2.55%)
Last: Apr 30, 2025, 08:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, MYTE scores 4 out of 10 in our fundamental rating. MYTE was compared to 120 industry peers in the Specialty Retail industry. MYTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYTE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MYTE was profitable.
  • MYTE had a negative operating cash flow in the past year.
  • MYTE had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: MYTE reported negative operating cash flow in multiple years.
MYTE Yearly Net Income VS EBIT VS OCF VS FCFMYTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -5.01%, MYTE is doing worse than 68.85% of the companies in the same industry.
  • MYTE has a Return On Equity (-8.64%) which is in line with its industry peers.
  • The Return On Invested Capital of MYTE (0.05%) is worse than 63.93% of its industry peers.
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROIC 0.05%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
MYTE Yearly ROA, ROE, ROICMYTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • Looking at the Operating Margin, with a value of 0.03%, MYTE is doing worse than 63.93% of the companies in the same industry.
  • MYTE's Gross Margin of 47.04% is fine compared to the rest of the industry. MYTE outperforms 72.13% of its industry peers.
  • In the last couple of years the Gross Margin of MYTE has remained more or less at the same level.
Industry RankSector Rank
OM 0.03%
PM (TTM) N/A
GM 47.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
MYTE Yearly Profit, Operating, Gross MarginsMYTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • MYTE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for MYTE has been increased compared to 1 year ago.
  • MYTE has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MYTE has been reduced compared to a year ago.
MYTE Yearly Shares OutstandingMYTE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYTE Yearly Total Debt VS Total AssetsMYTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • MYTE has an Altman-Z score of 4.23. This indicates that MYTE is financially healthy and has little risk of bankruptcy at the moment.
  • MYTE's Altman-Z score of 4.23 is amongst the best of the industry. MYTE outperforms 86.07% of its industry peers.
  • MYTE has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.19, MYTE is in the better half of the industry, outperforming 61.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.23
ROIC/WACC0.01
WACC7.41%
MYTE Yearly LT Debt VS Equity VS FCFMYTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • MYTE has a Current Ratio of 1.78. This is a normal value and indicates that MYTE is financially healthy and should not expect problems in meeting its short term obligations.
  • MYTE has a Current ratio of 1.78. This is in the better half of the industry: MYTE outperforms 76.23% of its industry peers.
  • A Quick Ratio of 0.22 indicates that MYTE may have some problems paying its short term obligations.
  • The Quick ratio of MYTE (0.22) is worse than 85.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.22
MYTE Yearly Current Assets VS Current LiabilitesMYTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 525.00% over the past year.
  • MYTE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.84%.
  • Measured over the past years, MYTE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 54.63% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYTE Yearly Revenue VS EstimatesMYTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 500M 1B 1.5B
MYTE Yearly EPS VS EstimatesMYTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 27.29, MYTE can be considered very expensive at the moment.
  • MYTE's Price/Earnings is on the same level as the industry average.
  • MYTE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.18.
  • With a Price/Forward Earnings ratio of 18.32, MYTE is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, MYTE is valued a bit cheaper than 61.48% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.01, MYTE is valued a bit cheaper.
Industry RankSector Rank
PE 27.29
Fwd PE 18.32
MYTE Price Earnings VS Forward Price EarningsMYTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • MYTE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MYTE is more expensive than 67.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.69
MYTE Per share dataMYTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • MYTE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MYTE's earnings are expected to grow with 54.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y115.23%
EPS Next 3Y54.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MYTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MYT NETHERLANDS PARENT BV

NYSE:MYTE (4/30/2025, 8:23:38 PM)

7.64

-0.2 (-2.55%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-11
Earnings (Next)05-14
Inst OwnersN/A
Inst Owner Change1.34%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Revenue(TTM)880.73M
Net Income(TTM)-35.85M
Analysts76.36
Price Target10.71 (40.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.51%
Min EPS beat(2)96.08%
Max EPS beat(2)206.95%
EPS beat(4)2
Avg EPS beat(4)50.27%
Min EPS beat(4)-50.98%
Max EPS beat(4)206.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.32%
Min Revenue beat(2)-3.03%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.24%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-0.99%
Revenue beat(12)4
Avg Revenue beat(12)-1.89%
Revenue beat(16)7
Avg Revenue beat(16)-0.73%
PT rev (1m)0%
PT rev (3m)49.57%
EPS NQ rev (1m)-140.01%
EPS NQ rev (3m)-111.77%
EPS NY rev (1m)0%
EPS NY rev (3m)17.95%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 27.29
Fwd PE 18.32
P/S 1.05
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 3.57
EV/EBITDA 49.69
EPS(TTM)0.28
EY3.66%
EPS(NY)0.42
Fwd EY5.46%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS7.27
BVpS3.42
TBVpS2.14
PEG (NY)0.09
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -8.64%
ROCE 0.06%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.07%
OM 0.03%
PM (TTM) N/A
GM 47.04%
FCFM N/A
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score3
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 4.11
Cap/Depr 47.13%
Cap/Sales 1.02%
Interest Coverage 0.05
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.22
Altman-Z 4.23
F-Score3
WACC7.41%
ROIC/WACC0.01
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)525%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y291%
EPS Next 2Y115.23%
EPS Next 3Y54.63%
EPS Next 5YN/A
Revenue 1Y (TTM)11.84%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%13.17%
Revenue Next Year9.06%
Revenue Next 2Y9.71%
Revenue Next 3Y9.58%
Revenue Next 5YN/A
EBIT growth 1Y101.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year188.35%
EBIT Next 3Y67.88%
EBIT Next 5YN/A
FCF growth 1Y18.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-407.95%
OCF growth 3YN/A
OCF growth 5Y33.41%

MYT NETHERLANDS PARENT BV / MYTE FAQ

What is the ChartMill fundamental rating of MYT NETHERLANDS PARENT BV (MYTE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MYTE.


What is the valuation status for MYTE stock?

ChartMill assigns a valuation rating of 3 / 10 to MYT NETHERLANDS PARENT BV (MYTE). This can be considered as Overvalued.


How profitable is MYT NETHERLANDS PARENT BV (MYTE) stock?

MYT NETHERLANDS PARENT BV (MYTE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for MYT NETHERLANDS PARENT BV?

The Earnings per Share (EPS) of MYT NETHERLANDS PARENT BV (MYTE) is expected to grow by 291% in the next year.